Clinical Trial Update: Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer [NA]

View source ↗

Summary

The clinical trial evaluating diagnostic value of molecular markers in renal (kidney) cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Kidney Neoplasms | NA | Status: TERMINATED